Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Athena swan Martin Phelps

The aim of the MRC MHU is to understand how mature blood cells are normally made from stem cells and how this is perturbed in common blood disorders. Ultimately, our purpose is to improve the management of patients with inherited and acquired blood diseases.

The MRC Molecular Haematology Unit (MHU) was founded in 1980 and is now located in the Weatherall Institute of Molecular Medicine. It includes fourteen research teams with over 100 scientists who share a common interest in understanding the process by which multipotential haemopoietic stem cells become committed and differentiate into the highly specialised cells found in the peripheral blood. In addition we study how these processes are perturbed in acquired and inherited blood diseases (eg thalassaemia, myelodysplasia and leukaemia). Our work is closely integrated with the provision of NHS service to patients with blood diseases. Some members are active clinicians, providing the Unit with access to clinical material and ensuring that our scientific developments are rapidly translated into improved clinical care.

Find out more about the MRC MHU.

MRC Weatherall Institute of Molecular Medicine

The MRC Molecular Haematology Unit is part of the MRC WIMM.

Find out more